SEC Form 4 · accession 0001437749-16-037786
Protagenic Therapeutics, Inc.\new · PTIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — See Remarks · Director · 10% Owner
Period of report
Jun 17, 2016
Accepted (ET)
Aug 18, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2016 | P | 60,211 | $1.25 | A | 4,299,379 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
60,211 Common Shares were acquired as a result of Dr. Armen cancelling $75,264 in debt owed to him by the issurer.